192 related articles for article (PubMed ID: 23118985)
1. The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.
Zeng X; Karnon J; Wang S; Wu B; Wan X; Peng L
PLoS One; 2012; 7(10):e48323. PubMed ID: 23118985
[TBL] [Abstract][Full Text] [Related]
2. Metastatic non-small cell lung cancer: costs associated with disease progression.
Fox KM; Brooks JM; Kim J
Am J Manag Care; 2008 Sep; 14(9):565-71. PubMed ID: 18778171
[TBL] [Abstract][Full Text] [Related]
3. Health care resource utilization and costs associated with advanced or metastatic nonsmall cell lung cancer in the United States.
Zhang X; Beachler DC; Masters E; Liu F; Yang M; Dinh J; Jamal-Allial A; Kolitsopoulos F; Lamy FX
J Manag Care Spec Pharm; 2022 Feb; 28(2):255-265. PubMed ID: 34854733
[No Abstract] [Full Text] [Related]
4. Costs for 5-year lung cancer survivors in a tertiary care hospital in South Korea.
Park YS; Kim SH; Park SK; Park BJ; Kim YT; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Shim YS; Yang SC
Lung Cancer; 2010 May; 68(2):299-304. PubMed ID: 19646776
[TBL] [Abstract][Full Text] [Related]
5. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
[TBL] [Abstract][Full Text] [Related]
6. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
[TBL] [Abstract][Full Text] [Related]
7. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
Wang YT; Huang G
Eur J Radiol; 2012 Aug; 81(8):e903-9. PubMed ID: 22698711
[TBL] [Abstract][Full Text] [Related]
8. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer.
Lakdawalla DN; Chou JW; Linthicum MT; MacEwan JP; Zhang J; Goldman DP
JAMA Oncol; 2015 May; 1(2):196-202. PubMed ID: 26181023
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Guideline-Recommended Initiation of Therapy, Outcomes, and Cost for Patients with Metastatic Non-Small Cell Lung Cancer.
Casebeer A; Antol DD; DeClue RW; Hopson S; Li Y; Khoury R; Michael T; Sehman M; Parikh A; Stemkowski S; Bunce M
J Manag Care Spec Pharm; 2018 Jun; 24(6):554-564. PubMed ID: 29799325
[TBL] [Abstract][Full Text] [Related]
10. Patterns of End-of-Life Oncologic Care for Stage IV Non-small Cell Lung Cancer in the United States.
Haque W; Verma V; Butler EB; Teh BS
Anticancer Res; 2019 Jun; 39(6):3137-3140. PubMed ID: 31177159
[TBL] [Abstract][Full Text] [Related]
11. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
12. Changing costs of metastatic non small cell lung cancer in the Netherlands.
Keusters WR; de Weger VA; Hövels A; Schellens JHM; Frederix GWJ
Lung Cancer; 2017 Dec; 114():56-61. PubMed ID: 29173766
[TBL] [Abstract][Full Text] [Related]
13. Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.
Brown J; Cook K; Adamski K; Lau J; Bargo D; Breen S; Chawla A
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):153-164. PubMed ID: 28335636
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care system.
Zeng X; Peng L; Li J; Chen G; Tan C; Wang S; Wan X; Ouyang L; Zhao Z
Clin Ther; 2013 Jan; 35(1):54-65. PubMed ID: 23328269
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003.
Cipriano LE; Romanus D; Earle CC; Neville BA; Halpern EF; Gazelle GS; McMahon PM
Value Health; 2011 Jan; 14(1):41-52. PubMed ID: 21211485
[TBL] [Abstract][Full Text] [Related]
16. Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model.
Buja A; Rivera M; De Polo A; Brino ED; Marchetti M; Scioni M; Pasello G; Bortolami A; Rebba V; Schiavon M; Calabrese F; Mandoliti G; Baldo V; Conte P
Thorac Cancer; 2021 Jan; 12(1):13-20. PubMed ID: 33219738
[TBL] [Abstract][Full Text] [Related]
17. Medical costs of lung cancer care in Japan during the first one or two years after initial diagnosis.
Awano N; Izumo T; Inomata M; Kuse N; Tone M; Takada K; Muto Y; Fujimoto K; Kimura H; Miyamoto S; Igarashi A; Kunitoh H
Jpn J Clin Oncol; 2021 Apr; 51(5):778-785. PubMed ID: 33506249
[TBL] [Abstract][Full Text] [Related]
18. Economics of the clinical management of lung cancer in France: an analysis using a Markov model.
Chouaïd C; Molinier L; Combescure C; Daurès JP; Housset B; Vergnenègre A
Br J Cancer; 2004 Jan; 90(2):397-402. PubMed ID: 14735183
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
[TBL] [Abstract][Full Text] [Related]
20. Costs of non-small cell lung cancer in the Netherlands.
van der Linden N; Bongers ML; Coupé VM; Smit EF; Groen HJ; Welling A; Schramel FM; Uyl-de Groot CA
Lung Cancer; 2016 Jan; 91():79-88. PubMed ID: 26589654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
